DOXIX | THCCX | DOXIX / THCCX | |
Total Expense Ratio | 0.33 | 1.50 | 22% |
Annual Report Gross Expense Ratio | 0.36 | 3.45 | 10% |
Fund Existence | 3 years | 2 years | - |
Gain YTD | 2.420 | 2.046 | 118% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 5000 | 50% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 94.7B | 146M | 64,863% |
Annual Yield % from dividends | 4.30 | 4.18 | 103% |
Returns for 1 year | 6.93 | 5.39 | 129% |
Returns for 3 years | 10.28 | N/A | - |
Returns for 5 years | N/A | N/A | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
DEOPX | 24.00 | 0.49 | +2.08% |
Davenport Equity Opportunities | |||
JAENX | 134.06 | 2.42 | +1.84% |
Janus Henderson Enterprise T | |||
BIPSX | 20.60 | 0.37 | +1.83% |
ProFunds Biotechnology UltraSector Svc | |||
EITMX | 106.09 | 1.64 | +1.57% |
Eaton Vance Tx-Mgd Growth 1.1 I | |||
TZINX | 2.56 | 0.03 | +1.19% |
Templeton Global Balanced Adv |